News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tanguler Tolga
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/28/2023 |
4
| Tanguler Tolga (EVP, Chief Commercial Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,277 shares
@ $0
Sold 122 shares
@ $193.18, valued at
$23.6k
Sold 562 shares
@ $193.93, valued at
$109k
Sold 625 shares
@ $194.94, valued at
$121.8k
Sold 64 shares
@ $195.65, valued at
$12.5k
Sold 103 shares
@ $197.08, valued at
$20.3k
|
|
| 03/01/2023 |
4
| Tanguler Tolga (EVP, Chief Commercial Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 5,000 restricted stock units
@ $0
Granted 10,352 options to buy
@ $190.01, valued at
$2M
|
|
| 02/03/2023 |
4
| Tanguler Tolga (EVP, Chief Commercial Officer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 73 shares
@ $223.97, valued at
$16.3k
Sold 963 shares
@ $225.8, valued at
$217.4k
Sold 561 shares
@ $226.62, valued at
$127.1k
Sold 4 shares
@ $227.38, valued at
$909.5
Sold 128 shares
@ $227.68, valued at
$29.1k
Sold 185 shares
@ $230.2, valued at
$42.6k
Sold 865 shares
@ $231.35, valued at
$200.1k
Sold 1,293 shares
@ $232.53, valued at
$300.7k
Sold 953 shares
@ $233.31, valued at
$222.3k
Exercised 5,025 restricted stock units
@ $0 |
|
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|